相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Demystifying the O-GlcNAc Code: A Systems View
Junfeng Ma et al.
CHEMICAL REVIEWS (2022)
Thermal Proteome Profiling Reveals the O-GlcNAc-Dependent Meltome
Dustin T. King et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)
Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant for Breast Cancer
Craig Furman et al.
MOLECULAR CANCER THERAPEUTICS (2022)
FOXA1 regulates alternative splicing in prostate cancer
Marco Del Giudice et al.
CELL REPORTS (2022)
FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact
Jasna Metovic et al.
CANCERS (2022)
Pioneer of prostate cancer: past, present and the future ofFOXA1
Mona Teng et al.
PROTEIN & CELL (2021)
A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations
Roser Zaurin et al.
NUCLEIC ACIDS RESEARCH (2021)
Quantitative Proteomics Reveals that the OGT Interactome Is Remodeled in Response to Oxidative Stress
Marissa Martinez et al.
MOLECULAR & CELLULAR PROTEOMICS (2021)
O-GlcNAc modification regulates MTA1 transcriptional activity during breast cancer cell genotoxic adaptation
Xueqin Xie et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
Darcie D. Seachrist et al.
CANCERS (2021)
Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer
Su H. Park et al.
SCIENCE ADVANCES (2021)
O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer
Matthew P. Parker et al.
CANCERS (2021)
Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin
Sohag Chakraborty et al.
CANCER LETTERS (2021)
The pioneer transcription factors Foxa1 and Foxa2 regulate alternative RNA splicing during thymocyte positive selection
Ching-In Lau et al.
DEVELOPMENT (2021)
NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44
Xiaoqing Zhang et al.
ONCOGENE (2021)
High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer
Yoshiya Horimoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer
Amaia Arruabarrena-Aristorena et al.
CANCER CELL (2020)
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer
Shuai Gao et al.
NATURE GENETICS (2020)
Age-related loss of neural stem cell O-GlcNAc promotes a glial fate switch through STAT3 activation
Charles W. White et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Proteomic profiling and genome-wide mapping of O-GlcNAc chromatin-associated proteins reveal an O-GlcNAc-regulated genotoxic stress response
Yubo Liu et al.
NATURE COMMUNICATIONS (2020)
The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014)
Shahin De Lara et al.
BMC CANCER (2019)
Resistance to bortezomib in breast cancer cells that downregulate Bim through FOXA1 O-GlcNAcylation
Yubo Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling
Silvia-E. Glont et al.
CELL REPORTS (2019)
JAM3 functions as a novel tumor suppressor and is inactivated by DNA methylation in colorectal cancer
Dan Zhou et al.
CANCER MANAGEMENT AND RESEARCH (2019)
MeCP2: an epigenetic regulator of critical periods
Nathalie Picard et al.
CURRENT OPINION IN NEUROBIOLOGY (2019)
SEdb: a comprehensive human super-enhancer database
Yong Jiang et al.
NUCLEIC ACIDS RESEARCH (2019)
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
Xiaoyong Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance
Yubo Liu et al.
CELL DEATH & DISEASE (2018)
Proteomic analysis of the OGT interactome: novel links to epithelial-mesenchymal transition and metastasis of cervical cancer
Jie Gao et al.
CARCINOGENESIS (2018)
Functional crosstalk among oxidative stress and O-GlcNAc signaling pathways
Po-Han Chen et al.
GLYCOBIOLOGY (2018)
A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2 '-Deoxycytidine
Benjamin R. Leadem et al.
CANCER RESEARCH (2018)
Tyrosine Phosphorylation of the Pioneer Transcription Factor FoxA1 Promotes Activation of Estrogen Signaling
Noritaka Yamaguchi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism
Ee Phie Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Protein O-GlcNAcylation: emerging mechanisms and functions
Xiaoyong Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Potential coordination role between O-GlcNAcylation and epigenetics
Donglu Wu et al.
PROTEIN & CELL (2017)
Suppression of OGT by microRNA24 reduces FOXA1 stability and prevents breast cancer cells invasion
Yubo Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Nucleation of DNA repair factors by FOXA1 links DNA demethylation to transcriptional pioneering
Yu Zhang et al.
NATURE GENETICS (2016)
FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function
Yeqing A. Yang et al.
NUCLEIC ACIDS RESEARCH (2016)
MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3
Hongwei Liang et al.
MOLECULAR CANCER (2015)
Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
Alexandra Naba et al.
BMC CANCER (2014)
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome
Yangyang Bian et al.
JOURNAL OF PROTEOMICS (2014)
Nuclear Mobility and Activity of FOXA1 with Androgen Receptor Are Regulated by SUMOylation
Paivi Sutinen et al.
MOLECULAR ENDOCRINOLOGY (2014)
Genome-Wide Binding of MBD2 Reveals Strong Preference for Highly Methylated Loci
Roberta Menafra et al.
PLOS ONE (2014)
DNA methylation reader MECP2: cell type- and differentiation stage-specific protein distribution
Congdi Song et al.
EPIGENETICS & CHROMATIN (2014)
FOXA1 is an independent prognostic marker for ER-positive breast cancer
Rutika J. Mehta et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Pioneer factors in hormone-dependent cancers
Kamila M. Jozwik et al.
NATURE REVIEWS CANCER (2012)
FOXA1: master of steroid receptor function in cancer
Michael A. Augello et al.
EMBO JOURNAL (2011)
Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers
Aurelien A. Serandour et al.
GENOME RESEARCH (2011)
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Antoni Hurtado et al.
NATURE GENETICS (2011)
Nucleosome-Interacting Proteins Regulated by DNA and Histone Methylation
Till Bartke et al.
CELL (2010)
Stable Chromatin Binding Prevents FoxA Acetylation, Preserving FoxA Chromatin Remodeling
Sarah Kohler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1
EA Williamson et al.
ONCOGENE (2006)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
